Log in or Sign up for Free to view tailored content for your specialty!
Neuroendocrinology News
FDA approves spinal cord stimulation system for diabetic pain
The FDA has approved the Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy, manufacturer Abbott announced in a press release.
Cushing’s syndrome treatment maintains reductions in urinary free cortisol for 12 months
Most adults with Cushing’s syndrome receiving levoketoconazole twice daily maintained reductions in mean urinary free cortisol levels during a 12-month maintenance period, according to findings from the SONICS study extended evaluation.
Log in or Sign up for Free to view tailored content for your specialty!
Presence of type 2 diabetes in acromegaly increases mortality and morbidity risks
Among adults with acromegaly, concomitant type 2 diabetes was associated with increased risks for overall mortality and for cardiovascular mortality and morbidity, researchers reported in The Journal of Clinical Endocrinology & Metabolism.
Osilodrostat normalizes urinary free cortisol in Cushing’s disease for most at 72 weeks
More than 80% of adults with Cushing’s disease receiving osilodrostat had normalized mean urinary free cortisol levels at 72 weeks of treatment, according to findings from the LINC 3 study extension.
Endoscopic surgery confers higher acromegaly remission rate than microscopic surgery
Endoscopic transsphenoidal surgery has the best remission rates and fewest postoperative complications for adults with acromegaly, according to findings from a systematic review.
More than 15% of patients at risk for rare cancers missed screenings during COVID
CHICAGO — In rare hereditary cancers such as paraganglioma/pheochromocytoma, where patients travel for their care, COVID caused a disruption in their screening and treatments, according to a poster presented during ASCO Annual Meeting.
Sleep deprivation may prevent counterregulatory adaptation to recurrent hypoglycemia
In a cohort of healthy young adult men, one night of sleep deprivation attenuated the adaptation to recurrent hypoglycemia by preserving neuroendocrine counterregulation and subjective awareness, according to study findings.
Oral octreotide efficacy maintained in more than 90% of adults with acromegaly at 3 years
ATLANTA — More than 90% of adults with acromegaly remained responders to oral octreotide 3 years after initiating treatment, according to findings from the MPOWERED open-label extension study presented at ENDO 2022.
VIDEO: New Cushing’s, acromegaly drug data prominent at ENDO annual meeting
ATLANTA — In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary research presented at the annual meeting of the Endocrine Society in Atlanta.
GH levels higher for postmenopausal women vs. men with controlled acromegaly
Among adults with controlled acromegaly, postmenopausal women had higher growth hormone levels than men despite similar insulin-like growth factor I levels, according to study data.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read